1.Guedes RA, Guedes VM, Freitas SM, Chaoubah A: Quality of life of medically versus surgically treated glaucoma patients. J Glaucoma 2013, 22(5):369–373.
2.McKean-Cowdin R, Wang Y, Wu J, Azen SP, Varma R, Los Angeles Latino Eye Study G: Impact of visual field loss on health-related quality of life in glaucoma: the Los Angeles Latino Eye Study. Ophthalmology 2008, 115(6):941–948 e941.
3.Quigley HA, Broman AT: The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 2006, 90(3):262–267.
4.Congdon N, O’Colmain B, Klaver CC, Klein R, Munoz B, Friedman DS, Kempen J, Taylor HR, Mitchell P, Eye Diseases Prevalence Research G: Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 2004, 122(4):477–485.
5.Skalicky SE, Martin KR, Fenwick E, Crowston JG, Goldberg I, McCluskey P: Cataract and quality of life in patients with glaucoma. Clin Exp Ophthalmol 2015, 43(4):335–341.
6.Costa VP, Smith M, Spaeth GL, Gandham S, Markovitz B: Loss of visual acuity after trabeculectomy. Ophthalmology 1993, 100(5):599–612.
7.Lichter PR, Ravin JG: Risks of sudden visual loss after glaucoma surgery. Am J Ophthalmol 1974, 78(6):1009–1013.
8.Turalba A, Payal AR, Gonzalez-Gonzalez LA, Cakiner-Egilmez T, Chomsky AS, Vollman DE, Baze EF, Lawrence M, Daly MK: Cataract Surgery Outcomes in Glaucomatous Eyes: Results From the Veterans Affairs Ophthalmic Surgery Outcomes Data Project. Am J Ophthalmol 2015, 160(4):693–701 e691.
9.Leleu I, Penaud B, Blumen-Ohana E, Rodallec T, Adam R, Laplace O, Akesbi J, Nordmann JP: Risk assessment of sudden visual loss following non-penetrating deep sclerectomy in severe and end-stage glaucoma. Eye (Lond) 2019, 33(6):902–909.
10.Monestam EI, Lundqvist BM, Jonsson AC: Long-time visual functional results of cataract surgery on low vision patients. Clin Ophthalmol 2008, 2(1):187–194.
11.Xu X, Sun Q, Ma YY, Zou HD: Vision-related Quality of Life Outcomes of Cataract Surgery in Advanced Glaucoma Patients. J Glaucoma 2016, 25(1):e5–11.
12.Melancia D, Abegao Pinto L, Marques-Neves C: Cataract surgery and intraocular pressure. Ophthalmic Res 2015, 53(3):141–148.
13.Coh P, Moghimi S, Chen RI, Hsu CH, Masis Solano M, Porco T, Lin SC: Lens Position Parameters as Predictors of Intraocular Pressure Reduction After Cataract Surgery in Glaucomatous Versus Nonglaucomatous Eyes. Invest Ophthalmol Vis Sci 2016, 57(6):2593–2599.
14.Perez-Bartolome F, Martinez-de-la-Casa JM, Arriola-Villalobos P, Fernandez-Perez C, Polo V, Garcia-Feijoo J: Ocular Surface Disease in Patients under Topical Treatment for Glaucoma. Eur J Ophthalmol 2017, 27(6):694–704.
15.Ramli N, Supramaniam G, Samsudin A, Juana A, Zahari M, Choo MM: Ocular Surface Disease in Glaucoma: Effect of Polypharmacy and Preservatives. Optom Vis Sci 2015, 92(9):e222–226.
16.Goldberg I, Graham SL, Crowston JG, d’Mellow G, Australian, New Zealand Glaucoma Interest G: Clinical audit examining the impact of benzalkonium chloride-free anti-glaucoma medications on patients with symptoms of ocular surface disease. Clin Exp Ophthalmol 2015, 43(3):214–220.
17.Tham CC, Kwong YY, Leung DY, Lam SW, Li FC, Chiu TY, Chan JC, Lam DS, Lai JS: Phacoemulsification versus combined phacotrabeculectomy in medically uncontrolled chronic angle closure glaucoma with cataracts. Ophthalmology 2009, 116(4):725–731, 731 e721–723.
18.Tham CC, Kwong YY, Baig N, Leung DY, Li FC, Lam DS: Phacoemulsification versus trabeculectomy in medically uncontrolled chronic angle-closure glaucoma without cataract. Ophthalmology 2013, 120(1):62–67.
19.Mills RP, Budenz DL, Lee PP, Noecker RJ, Walt JG, Siegartel LR, Evans SJ, Doyle JJ: Categorizing the stage of glaucoma from pre-diagnosis to end-stage disease. Am J Ophthalmol 2006, 141(1):24–30.
20.Gregori NZ, Feuer W, Rosenfeld PJ: Novel method for analyzing snellen visual acuity measurements. Retina 2010, 30(7):1046–1050.
21.Topouzis F, Tranos P, Koskosas A, Pappas T, Anastasopoulos E, Dimitrakos S, Wilson MR: Risk of sudden visual loss following filtration surgery in end-stage glaucoma. Am J Ophthalmol 2005, 140(4):661–666.
22.Musch DC, Gillespie BW, Niziol LM, Janz NK, Wren PA, Rockwood EJ, Lichter PR, Collaborative Initial Glaucoma Treatment Study G: Cataract extraction in the collaborative initial glaucoma treatment study: incidence, risk factors, and the effect of cataract progression and extraction on clinical and quality-of-life outcomes. Arch Ophthalmol 2006, 124(12):1694–1700.
23.Leleu I, Penaud B, Blumen-Ohana E, Rodallec T, Adam R, Laplace O, Akesbi J, Nordmann JP: Central 10-degree visual field change following non-penetrating deep sclerectomy in severe and end-stage glaucoma: preliminary results. Graefes Arch Clin Exp Ophthalmol 2018, 256(8):1489–1498.
24.Aggarwal SP, Hendeles S: Risk of sudden visual loss following trabeculectomy in advanced primary open-angle glaucoma. Br J Ophthalmol 1986, 70(2):97–99.
25.Moster MR, Moster ML: Wipe-out: a complication of glaucoma surgery or just a blast from the past? Am J Ophthalmol 2005, 140(4):705–706.
26.Ozeki N, Yuki K, Shiba D, Tsubota K: Evaluation of Functional Visual Acuity in Glaucoma Patients. J Glaucoma 2017, 26(3):223–226.
27.Hayashi K, Hayashi H, Nakao F, Hayashi F: Effect of cataract surgery on intraocular pressure control in glaucoma patients. J Cataract Refract Surg 2001, 27(11):1779–1786.
28.Di Staso S, Sabetti L, Taverniti L, Aiello A, Giuffre I, Balestrazzi E: Phacoemulsification and intraocular lens implant in eyes with primary angle-closure glaucoma: our experience. Acta Ophthalmol Scand Suppl 2002, 236:17–18.